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To study the metabolic consequences of coba1 amin-folate 
interactions in vitamin Bi2 deficiency, a simple in vitro assay of 
folate-dependent I^C-formate incorporation into 1^-L-serine by 
peripheral leukocytes has been developed and applied to B]2 deficient 
and folate deficient patients. In five vitamin B12 deficient patients, 
incorporation was significantly reduced, suggesting that cobalamin 
deficiency depletes the intracellular pool of free tetrahydrofolate, 
required in this reaction as carrier of the I^C-formate. The possible 
mechanisms by which this might occur are discussed. No defect in 
I^C-formate incorporation into 1^C-L-serine was observed in two folate 
deficient patients, but the significance of this finding is speculative 
because of the small number of patients studied. Leukocytes from 
vitamin B12 deficient patients also demonstrated a reduced capacity to 
oxidize 1^C-3-propionate to 1^C02 but normal 1^C02 production from 
1^C-1 ,4 -succinic acid. These observations suggest a block in the 
oxidative catabolism of propionate at the B12~dependent methylmalonyl 
CoA mutase step. No defects in propionate metabolism were observed 
in the folate deficient patients. 
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From little-understood disorders of insidious onset, unknown 
etiology, and usually fatal outcome, the megaloblastic anemias have 
evolved over the past fifty years into a well-defined group of 
eminently treatable diseases due to deficiency of vitamin or 
folates. They have been the subject of increasingly sophisticated in¬ 
vestigations, the results of which have had broad implications for the 
understanding of regulatory mechanisms in intermediary metabolism 
both at the cellular and whole-organism level. In spite of this 
probing, however, fundamental questions remain about the mechanisms 
by which deficiencies of vitamin and/or folic acid produce anemia. 
The objectives of this paper will be twofold: first, to explore the 
hypotheses which have been advanced to account for the clinical 
similarities - and differences - between the syndromes produced by lack 
of these essential nutrients; and second, to review the sti11-unsett1ed 
question of what in fact constitutes folate "deficiency", and how it 
can best be assessed in the clinical setting. In terms of this 
second objective, the results of a study by the author of a recently 
developed in vitro assay for detecting folate deficiency^ will be 
presented. The data derived from the application of this same assay 
to the B12 deficient patient, and of an indirect assay of vitamin B^- 
dependent methy1ma1ony1 CoA mutase activity^ to both the folate and 
B^2 deficient patient, will also be presented and discussed in the 
context of present understandings of cobalamin - folate interdependence. 
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A comprehensive review of the fascinating but voluminous 
literature concerning the historical, clinical, morphologic, genetic, 
and immunologic aspects of the megalob1astic anemias is beyond the 
scope of the present effort, but the field has recently been surveyed 
admirably by Chanarin^ and by Harris and Ke11ermeyer.^ 
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VI TAM IN B12 
Only five years after Addison's description in 1855 of what 
may have been what we now recognize as pernicous anemia, Austin Flint 
offered the following hypothesis concerning its pathogenesis: 
I suspect that in these cases there exists degenerative 
disease of the glandular tubuli of the stomach. . . . Fatal 
anemia must follow an amount of degenerative disease reducing 
the amount of gastric juice so far that assimilation of food 
is rendered wholly inadequate to the wants of the body. . . . 
I shall be ready to claim the merit of this idea when the 
difficult and laborious researches of someone have shown it to 
be correct.5 
As predicted, however, little progress was made in either the under- 
standing or therapy of the disease until 1926, with Minot and Murphy's0 
introduction of an effective dietary treatment. Castle's studies,7 
resulting eventually in the isolation of intrinsic factor from gastric 
secretions, the crystallization of cyanocobalamin in 19^8, and the 
elucidation of its structure in 1955, have led to our present under¬ 
standing of the nature of the missing vitamin, and the means by which 
its deficiency can arise in individuals with apparently adequate 
nutrition. 
o 
St ructu re° 
Crystalline vitamin consists of a planar tetrapyrrole 
nucleus, with three of the rings joined by «x-methene bridges, as in 
the porphyrins. In contradistinction to the porphyrins, the ring is 
completed by a direct carbon-to-carbon bond between cx-positions of 
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the pyrroles designated A and D, and the four bases are partially 
reduced. A trivalent cobalt atom lies at the center of the ring 
structure; four of its six coordinate binding sites are occupied in 
one plane by the pyrrole nitrogens. The 5th binds to base nitrogen 
of a nucleotide lying "below” the planar ring. In addition to the 
Co-N coordinate bond, the nucleotide, which is a 5,6,-dimethyl- 
benz i mi dazol e base linked by an <x-glycoside bridge to ribose-3" 
phosphate, is also bound to the tetrapyrrole nucleus through its 
phosphate group. This ties it, through an ami noisopropanol linkage, 
to a propionic acid side chain of the D ring. "Above" the nucleus 
lies a cyano group, which by an ionic bond is tied to the sixth 
coordinate site of the central Co atom. Cyanocoba1 amin probably does 
not occur normally in vivo, and in the coenzymatica11y active forms of 
the vitamin the sixth Co coordinate site is occupied by a methyl group 
or by 51-deoxyadenosy1 ribonuc1eoside. It appears that in vivo 
synthesis of the coenzymes involves progressive reduction of Co'*® to 
Co® before addition of the active substituent at the sixth position. 
The structure of one of the coenzymes, 51-deoxyadenosy 1 cobalamin 
(dA-Bi2) is illustrated in Figure 1. 
Nutritional Aspects^ 
Vitamin B^ is synthesized by bacteria through essentially 
the same metabolic pathway as are the pyrroles in heme. It does not 
occur in the plant kingdom, and in the higher animals is derived solely 
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Figure 1. Structure of 5'-deoxyadenosylcobalamin. From 
Harris JW, Kellermeyer RW: The Red Cell. Cambridge: 
Harvard University Press, 1970, p 3TT5Y 

-6- 
from dietary sources. It is so ubiquitous among many soil organisms 
that even domestic water supplies may serve as dietary sources, and 
bacterial contamination of the exclusively vegetarian diets of some 
mammals may be sufficient to prevent deficiency. Animal food sources 
contain significant amounts of the vitamin, the highest concentration 
occurring in liver. It has been estimated that essentially all 
dietary is available for absorption, limited only by the 2-3 meg 
maximum daily capacity of the intrinsic factor-ileal receptor 
absorption system. 
Biochemist ry 
The two coenzymes forms of vitamin B^ ate involved in re- 
O 
actions which have been grouped by Silber and Moldow0 into two classes. 
Those requiring dA-B^ involve hydrogen transfer along a carbon chain, 
with reciprocal movement of a second group in the opposite direction: 
R 
R" H 





<-> R1— C — C— R" 1 
I I 
H R" 
Only one such pathway, the isomerization of L-methylmalonyl CoA to 
succinyl CoA, has been convincingly demonstrated in man. Decreased 
activity of methylmalonyl CoA mutase, as measured either by increased 
urinary methylmalonic acid excretion^ or by decreased production 
from leukocyte homogenates incubated with ^C(carboxy)-D-methy1ma1ony1 
CoA^ has been reported as an index of the B12 deficiency state in man. 
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An appreciation of the role played by the other 
coenzyme, methylcobal amin (CH^-B-^) in mammalian systems arose from 
studies in rats demonstrating capability for de novo synthesis of the 
methyl group of methionine from ^C-formate.^ In 1951, Bennet et al. 
reported that the liver-derived factor, permitting growth of rats on a 
diet free of labile methyl groups but containing folic acid and homo¬ 
cysteine was vitamin B^-^ Additional evidence linking B^ with 
methionine biosynthesis was derived from a strain of Escherichia coli 
requiring either B^2 or methionine for growth. It was demonstrated 
that in the presence of cobalamin, the organism synthesized methionine 
de novo provided that the medium also supplied homocysteine, folate, 
and a source of single-carbon units.Further investigations on 
the same organism revealed that the immediate methyl donor for the 
reaction was N^-methy1tetrahydrofolate (N^-CH^-FH^).^ In 1954 
Buchanan and co-workers reported a partially purified enzyme preparation 
17 1 o 
from pig liver, with similar properties and cofactor requirements. ' ’ 
Enzyme activity was found to directly parallel B^ content of the 
preparation. Requirements for FADH2 and S-adenosyl methionine 
(Met-S-Ad) were also demonstrated, and the latter was shown to serve a 
catalytic rather than stoichiometric function in the methylation 
process. On the basis of these studies the following sequence of re¬ 
actions has been proposed to take place: 
Met-S-Ad HCys-S-Ad 
^ ^ 










The precise catalytic role of S-adenosyl methionine remains unclear. 
Taylor and Weissbach^ have suggested that a "priming" methylation of 
the cobamide prosthetic group of the holoenzyme is involved, since 
methyl iodide can replace Met-S-Ad in their assay (E_. col i) system. 
They postulate that subsequent regeneration of CH3-B12 with each methyl 
group transfer to homocysteine results from stoichiometric amounts of 
substrate N^-CH^-FH^. 
A coba1 amin-independent methyl transferase active only for 
the triglutamate form of N^-CH^-FH^ has been identified in other strains 
of E_. col i .^0 Evidence suggesting its presence in human liver has also 
been presented,21 but its quantitative significance in mammalian 
systems is unknown. The well-established actions of coenzymes are 
summarized in Table 1. The implications of searches for other metabolic 
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The relationship of an essential nutrient other than 
vitamin Bi2 to the development of megaloblastic anemia began to be 
elucidated in 1931, with the recognition of a "pernicious anemia of 
22 
pregnancy" occurring in Hindu women. In contrast to Addisonian 
anemia, achlorhydria and neurological signs of posterolateral column 
degeneration were consistently absent.^3 jn addition, these patients 
responded with hematologic remissions both to crude - but not purified - 
22 
liver extract, and to "marmite", an autolyzed yeast preparation, 
2k 
again separating them from patients with classical pernicious anemia. 
The initial hypothesis that chronic dietary deprivation of vitamins 
2k 
A and C was responsible for this form of megaloblastic anemia was 
subsequently shown to be erroneous, but studies of an experimental 
megaloblastic anemia in monkeys and many bacteriologic growth studies 
were required before folic acid was shown to be the active principle 
in the therapy.^ 
Biochemistry of the Folates 
This subject and most other aspects of these compounds have 
9 A 
been exhaustively reviewed recently, and only a summary emphasizing 
pertinent points will be attempted here. 
The parent compound of the folates is pteroy1monoglutamic 
acid (PGA). Although it functions effectively in supporting growth 
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of organisms dependent on folates, it, like cyanocoba1 amin, is merely 
a stable isolatable form not coenzymatical 1y active in vivo. PGA can 
be considered to consist of three portions: the pteridine, para- 
aminobenzoic acid, and L-glutamic acid. Naturally occurring folates 
differ from PGA in three respects. First, the pteridine nucleus is 
reduced at positions 5,6,7, and 8. Second, single-carbon units at 
different oxidation states are bound covalently to the nitrogens at 
positions 5 or 10 or bridged between them. Third, additional L-glutamyl 
residues may be linked to the parent compound through unique peptide 
linkages; i.e., tx-amino to the v-carboxyl group of the proximal 
glutamate. Folates coenzymatica11y active in man are probably all 
monoglutamates; food folates are primarily hexa- and heptag1utamates 
and are acted on by an enzyme termed "conjugase" to liberate the mono¬ 
glutamates prior to absorption from the gastrointestinal tract.^7 
Other details of the absorptive process will be discussed later. The 
structures of PGA, monoglutamate coenzymes, and the triglutamate are 
illustrated in Figure 2. 
Folates function in a great many one-carbon transfer re¬ 
actions in mammalian systems. Their principal roles are summarized in 
Figure 3- In a general sense, this schema simply suggests what has been 
confirmed experimentally, that labelled carbon is readily intercon¬ 
vertible in vivo among formate, formaldehyde, serine ( ^-carbon), 
purine (2- or 8-carbon), histidine (imidazole-2-carbon), or methionine 
(methyl carbon). Of key importance to the present discussion is that, 
in mammalian systems, one of these reactions, the methylation of homo¬ 
cysteine, is also dependent upon the presence of cobalamin, as discussed 
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Kellermeyer RW: The Red Cell. Cambridge: Harvard University 
Press, 1970, p 395. 
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Figure 3. Folate-dependent Reactions. The central role of vitamin 
B^2 regeneration of free tetrahydrofolate is illustrated. From 
Herbert V: Drugs effective in the megaloblastic anemias. The 
Phamacological Basis of Therapeutics, Goodman LS, Gilman A eds. 
New York: The MacMillan Company, 1970. 
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THE ASSESSMENT OF FOLATE DEFICIENCY 
Although more than four decades have elapsed since publication 
of Wills' initial studies of folate deficiency, significant unsettled 
problems remain to confront the clinician attempting to assess folate 
nutritional status. Indeed, until Herbert documented the progressive 
development of the deficiency syndrome in a normal subject maintained 
on a folate-poor diet, there was not general agreement that megalo¬ 
blastic anemia could arise solely as a consequence of dietary folate 
deprivation. While this study resolved the above issue, it implicitly 
revealed another; if megaloblastic anemia, hematological 1y indistin¬ 
guishable from that resulting from gastric atrophy, could arise 
secondary to folate deprivation, how were the two syndromes to be 
distinguished clinically? Prior to I960, the distinction was made on 
the basis of the non-hematologic accompaniments of B1 2 deficiency. 
Absence of neuropathy was obviously less than reliable in this regard 
since it was not a universal accompan i ment of anemia caused by 
deficiency. The sensory neuropathy commonly observed in alcoholic 
patients further diminished the reliability of the neurologic features 
as a discriminatory tool. Achlorhydria, consistently present in 
Addisonian anemia, was also found to have limited usefulness in the 
differential diagnosis, since it occurred in a significant percentage 
of older normal individuals. The demonstration of "histamine-fast" 
achlorhydria and achylia gastrica were found to have greater 
diagnostic value, but at the expense of considerable discomfort to the 
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patient. In summary, "folate deficiency" was considered a diagnosis 
made primarily by exclusion. 
Attempts to refine the clinician’s ability to differentiate 
from folate deficiency have been directed along five major avenues. 
Each of these will be discussed below. 
Morphologic Distinctions between and Folate Deficiencies 
From time to time, various aspects of the peripheral or 
marrow morphology have been touted as characteristic more of one anemia 
than the other, but these assertions have uniformly been found to be 
without merit. For example, it has been the "clinical impression" of 
many hematologists that extreme macrocytosis is seen principally in Bi2 
deficiency.^ McPhedran et a 1. 1 s recent study of 100 consecutive 
patients with macrocytosis demonstrates the fallacious nature of this 
belief;^® the highest MCV's were actually observed in cirrhotic patients 
with folate deficiency but normal plasma B^ levels. 
Therapeutic Trials 
After Wills' initial studies it was felt by some that the 
hematinic in "marmite" was the same active principie, present in fresh 
liver, which was effective in pernicious anemia. Even after this was 
shown not to be the case,^ many physicians persisted in the treatment 
of Addisonian anemia with folate, a practice which led to the demonstration 
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by Vilter et_ aj_. in 1950 that while folate could regularly induce 
hematologic remissions in pernicious anemia, it seemed to exacerbate 
or even precipitate neuropathy.^^ Vilter et al. proposed that folate 
exerted a "mass action" effect on hematopoe i s i s in deficiency, 
forcing some biosynthetic reactions in the nuc1eoprotein pathway which 
were also dependent on cobalamins. He suggested that this effect 
could be deleterious in terms of the separate needs of non-hematologic 
tissues for These studies led eventually to the formulation of a 
concept distinguishing the physiologic from the pharmacologic effects 
of folate. In I960 Marshall and Jandl published their studies 
demonstrating the utility of this concept.^ Patients classified by 
other criteria as folate-deficient were found to respond with brisk 
reticu1ocytoses to daily parenteral administration of 400 meg of PGA. 
No additional reticu1ocytosis was observed when the dose was increased 
to 15 mg daily. Just the opposite was found in patients with 
Addisonian anemia; no responses occurred with the smaller dose, but all 
patients had maximal hematologic responses to 15 mg of parenteral 
folic acid. Great enthusiasm was expressed for the clinical trial as a 
diagnostic tool, but this approach has not received general acceptance 
for several practical reasons. The financial cost of the twenty-odd 
days of observation required for an adequate trial is often prohibitive. 
Complications such as congestive heart failure precipitated by prolonged 
profound anemia may render such an extended undertaking unjustifiable. 
oO 
Deficiency not yet manifested by anemia'11 might be undetectable by this 
approach. Finally, deficiencies of the two vitamins may coexist, which 
further complicates the design and interpretation of such studies. 

-17- 
Assay of Folate Activity in Human Tissues 
Greater success has been experienced with attempts to assess 
folate status by measurement of the quantity of vitamin present in body 
fluids. Although early reports predicted the futility of this approach,33 
a bioassay of "folic acid activity" in human serum which appeared to be 
of remarkable clinical utility was published in 1959-3^ Subsequently, 
it was shown that early workers' inability to detect folates in the 
serum of fasting normal subjects was the consequence of two unappre¬ 
ciated factors; i.e., the specific auxotrophisms of various assay 
organisms^ and the nature of the folate coenzymes present in human 
serum.3& Almost all serum folate was found to be N^-CH^-FH^, which 
would support the growth of Lactobacillus casei but not Streptococcus 
faeca1is , which had been used as the assay organism by most earlier 
investigators. 
Although minor modifications of the original assay technique 
have been introduced, the estimation of serum folate by bioassay has 
become a valued clinical tool. It is not without its shortcomings. 
In practical terms the assay is tedious, time-consuming, and therefore 
not generally available. It is subject to the same types of distortions 
as are other bioassays; e.g., artifactual 1y low values resulting from 
the presence of antibiotics or antimetabolites in the serum. Of greater 
clinical import, it is perhaps too sensitive to the fluctuations of 
normal diets. While Herbert was able to define a "normal range" between 
7 and 2b ng/ml of serum folic acid activity, the statistical basis of 
/ 
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this definition was never stated, and he was forced to include groups 
classed "suggestive of deficiency" and "indeterminate" to describe 
subjects with values between 3-0 and 6.9 ng/ml.37 His own study of 
experimental folate deficiency demonstrated that only three weeks of 
negative folate balance sufficed to produce a fall in serum folate to 
less than 3.0 ng/ml (indicative of "unequivocal deficiency"). A full 
18 weeks elapsed before macrocytosis appeared, and only after 19 weeks 
of essentially no folate intake did megaloblastic anemia develop.^8 
In summarizing the experience of many observers, Chanarin noted that 
approximately one-third of all hospitalized patients had serum folates 
below the normal range.38 Finally, it is possible that deceptively 
normal values might occur in individuals depleted of folate stores, 
if the specimen assayed were obtained within six hours of a folate-rich 
meal.39 For these reasons, there is now a general consensus that quite 
apart from the technical difficulties of the assay, the sensitivity of 
the serum test renders it useless as a screening procedure and 
relegates it to a confirmatory role in suspected folate deficiency. 
Since the information actually sought in measurement of folate 
levels is an estimation of the status of intrace 11u1 ar active coenzyme 
pools, it might be predicted that direct tissue assays might be of 
greater diagnostic value. This is also suggested by Herbert's folate 
deprivation study, in which erythrocyte folates were measured by bio- 
oO 
assay. ° Abnormally low values of this parameter did not appear until 
17 weeks, much closer temporally to the appearance of clinical deficiency. 
In an attempt to correlate the morphologic manifestations of deficiency 
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with biochemical changes, Cooper and Lowenstein studied 63 patients 
who had serum B^? serum folate, and red cell folate determinations 
made within 48 hours of bone marrow aspiration.^® None of these 
patients was receiving antimetabolites or antibiotics, and none was 
presumed to have pernicious anemia. Low serum folates (<.4.1 ng/ml) 
were found in 48 of the 63- Only 21 of these 48 had any megaloblastic 
marrow changes. Every megaloblastic marrow was accompanied by either a 
depressed RBC folate (17 patients) or low serum B1 2 (4 patients). In 
contrast, among the 27 patients with normoblastic maturation but 
depressed serum folates, RBC folates were normal in all except 4 or 5. 
The authors concluded that the serum folate was the more valuable 
screening test since it identified all megaloblastic patients. An 
alternative reading of these results is that measurement of both red 
cell folate and serum B^ will identify all megaloblastic patients 
with far fewer "false positive" tests. This is the more widely accepted 
position, and the erythrocyte folate determination has gradually replaced 
the serum folate estimation as the most widely used clinical indicator 
of tissue folate depletion.^ 
Although the red cell folate has been shown to be an extremely 
valuable clinical tool, some theoretical arguments can be raised 
against its use as an index of "tissue" folate stores. The tissue being 
assayed is highly atypical; the very biosynthetic processes believed to 
be deranged in mega 1ob1astosis are inoperative in the mature erythrocyte. 
Moreover, red cell folate is not freely exchangeable with other tissue 
pools. Intraerythrocytic folate seems to be primarily in the form of 
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high pol ygl utamates^ trapped i ntracel 1 ul arl y for the life of the 
erythrocyte, and the cell's entire folate pool is acquired before 
it reaches maturity.^ Of more practical significance, the test cannot 
be relied on to assess folate status in the presence of B12 deficiency. 
This intriguing problem will be discussed further (vide infra p. 45). 
Minimal data is available on the folate content of liver. 
Total hepatic folate content seems to correlate poorly with the fasting 
serum folate.^ The "normal range" is unknown, but what values are 
available suggest that liver folate is depleted in nutritional folate 
deficiency severe enough to produce anemia. It is perhaps normal in 
human def iciency but reduced in 2~depl eted rats.The 
necessity of resorting to invasive techniques in the acquisition of this 
type of information obviously diminishes its clinical usefulness. 
Recently a non-competitive binding radioassay of folate suf¬ 
ficiently sensitive to measure accurately the range of concentrations 
48 
present in human serum has been published. Although the peculiarities 
of bioassay are obviated by this approach, the objections to any measure¬ 
ment of serum folates as the index of body stores remain pertinent. 
Application of the test to measurement of red cell folate would seem to 
be an appropriate modification. 
Folate Loading Studies 
While intravenously administered folic acid has been found to 
disappear more rapidly from plasma in folate deficient subjects than 
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in normal controls, clearance of some forms of folate may actually be 
retarded in deficient patients.37 Such studies have had wide¬ 
spread investigative application (vide infra p. 30), but they are too 
complex to be of routine assistance in the differential diagnosis of 
megaloblastic anemia. 
Studies of Metabolic Derangements Produced by Folate Deficiency 
As might be apparent from inspection of Figure 3, the 
metabolic disturbances to be anticipated as a consequence of the 
depletion of folate coenzymes are numerous. Many attempts to assess 
effective folate stores have been based upon searches for abnormal 
accumulation or depletion of metabolites involved in folate-dependent 
single-carbon transfers. Perhaps the most widely employed of these is 
the so-called FIGIu test. In 1953 a metabolite of histidine was found 
to be present in increased amounts in the urine of folate deficient 
rats.^9 Subsequently, this substance was identified as formimino- 
glutamate (FIGIu). In the presence of a formiminotransferase enzyme 
and FH^ as acceptor, free L-glutamate was liberated with the formimino 
group passing into the "single-carbon pool". In the absence of folate, 
catabolism of histidine was interrupted at FIGIu, which spilled into 
the urine. In 1959 Broquist and Luhby found increased amounts of FIGIu 
in the urine of folate deficient patients.50 Although no actual data 
were given, he claimed that the finding was specific for folate 
deficiency; i.e., normal or absent excretion was supposedly found in 
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persons with pernicious anemia. This test has been widely adopted 
clinically in slightly modified form. Most investigators have admin¬ 
istered two to twenty gram doses of histidine orally, then measured 
urine FIGIu. Excellent concordance has been found between the results 
Cl Zl 1 
of this assay and the red cell folate in individual patients. ’ 
As experience has accumulated, the test has been shown to be less 
specific than originally hoped. Abnormally elevated urine FIGIu's in 
pernicious anemia have been a frequent finding, even in the absence of 
a low serum or red cell folate.Increased amounts of the com¬ 
pound also appear in the urine of patients with liver disease, 
Hodgkin's disease, and myelosclerosis, in the absence of either vitamin 
deficiency; false negatives are often observed in the megaloblastic 
C 1 
anemia of pregnancy or in the p'eserice of severe protein deficiency. 
The FIGIu test is no longer performed routinely in most institutions. 
Employing far more "physiologic" doses (0.5 mg) of 
1^C-2(imidazole)-L-histidine, injected intravenously, Fish and co¬ 
workers were able to differentiate folate deficient from B]2 deficient 
1A 52 
subjects by monitoring CO2 expired over a two hour period. 
1 A 
Cumulative CO2 excretion was reduced by an order of magnitude, and 
the time to maximal minute excretion (Tmax) was delayed severalfold 
among folate deficient patients as compared with controls or B12 
deficient subjects. The latter two groups were indistinguishable. 
Although these data are impressive, the number of patients studied is 
small and the test is not widely available. Moreover, a recent attempt 
to demonstrate a similar defect in vitro has been unsuccessful. 
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Erythrocytes of rats which had been rendered folate deficient or 
deficient by means of dietary restriction were incubated with minute 
amounts of ^C-2 (i mi dazol e)-L-h i st i d i ne. No differences were observed 
in either Tmax or cumulative evolution of between the two 
deficient groups and control animals.^3 The interpretation of this 
finding in a highly specialized system such as the red cell is of 
course problematic. 
Since the biosynthesis of the purine nucleus is completed 
by transformy1 ation from a folate coenzyme to 5~amino-4-imidazole 
carboxamide (AICAR), yielding inosine monophosphate (IMP), abnormal 
accumulations of AICAR have been sought as an index of significant 
folate depletion. Surprisingly, the first such effort indicated that 
increased urinary excretion of AICAR was not observed in folate 
deficient patients but was universally detected in untreated pernicious 
anemia. Another report soon followed, however, in which this dis¬ 
criminatory capacity was refuted,^5 and this test has fallen into disuse. 
Recently a study purporting to demonstrate a more generalized 
derangement of single-carbon metabolism specific for folate deficiency 
has appeared. Tran et_ aj_. incubated erythrocytes of rats made 
deficient in or folate with ^C-formate and measured the ^CC^ 
evolved over three hours. B1 2 deficient animals yielded results 
indistinguishable from controls, but ^CC^ production by red cells of 
folate deficient rats was markedly reduced.53 The study is unfortunately 
virtually uninterpretab1e for several reasons. No parameters were re¬ 
ported which assured that the animals were indeed depleted of one or 
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the other vitamin; in fact, the "folate deficient" group may have been 
choline deficient. In addition, reproducibility between experiments 
seems to have been poor. Final ly, an earl ier j_r^ v i vo study in rats 
had demonstrated abnormalities of endogenous and exogenous formate 
metabolism which were caused by either vitamin deficiency.5^ 
The interconversion of glycine and serine is yet another 
folate-dependent b i ot rans format i on , 57 N^N ^-CH2-FH 4 being the required 
cofactor. In rats, folate deficiency was shown to abolish the 
incorporation of ^C-formic acid into the £ -carbon of serine of 
hepatic and visceral protein,58 but no abnormality of glycine-serine 
interconversion was observed when this was first studied in human folate 
deficiency.59»50 The techniques employed were insensitive (measurement 
of plasma serine before and after 25 gram glycine infusion) and the 
patients studied less than ideal (all had tropical sprue and megalo¬ 
blastic marrows; all responded to subsequent folate treatment). In 
1970, a preliminary report appeared in which defective glycine-serine 
interconversion, assessed by ^C-formate incorporation into the -carbon 
of serine of lymphocytes in vitro, was found in 8 patients with folate 
deficiency.^ A "relative" defect was also observed among 12 patients 
characterized only as having gastrointestinal malabsorption and normal 
indices of folate stores. In the folate deficient group the defect was 
not entirely abolished even after four to six weeks of daily oral PGA 
therapy. Unfortunately, no patients with B1 2 deficiency were reported, 
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which renders the specificity of the assay problematic.3 Some of 
the experimental work to be presented here will be directed towards 
questions raised by this report; e.g., whether the results can be 
duplicated, what specificity can be claimed for the assay if it is 
indeed a reliable index of folate deficiency, and what significance can 
be ascribed to the presence or absence of such abnormalities in vitamin 
deficiency. 
aWhile the present studies were in progress, a more detailed report of 
this work appeared.The authors stated that they had observed im¬ 
paired serine formation in lymphocytes from pernicious anemia patients, 
but no data were given. 
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THE BIOCHEMICAL BASIS OF MEGALOBLASTOSIS 
Many of the cytomorphologic features of the megaloblastic 
anemias suggested a profound derangement of metabolic events occurring 
within the cell nucleus, but the nature of these changes could not have 
been appreciated prior to the elaboration of our present concepts of 
the structure and function of the genetic apparatus. Elucidation of 
the several roles of folates in the synthesis of both purines and 
pyrimidines rendered attractive the concept of impaired nucleic acid 
biosynthesis as the central lesion in megaloblastic erythropoeisis. 
The 1ong-recognized "maturation arrest" and "nuc1eocytop 1asmic 
dyssynchrony" so characteristic of the megaloblastic marrow were 
interpreted as morphologic expressions of this biochemical abnormality. 
This thesis was supported by the observations that uracil or thymine 
given orally were capable of inducing hematologic remissions.^1 
Rundles and Brewer reported that oral orotic acid therapy of pernicious 
anemia resulted in a limited remission in 1958. Morphology had more 
specific information to reveal about underlying biochemical mechanisms, 
however; hemoglobinization (protein synthesis) and hence messenger RNA 
synthesis seemed to proceed relatively unimpaired in the megaloblast. 
In retrospect, Thorell's earlier demonstration in 19^7 of the presence 
of normal to increased amounts of RNA in mega 1ob1astsD was supportive 
of this concept. In 1963, Williams and coworkers^ added the informa¬ 
tion that while incorporation of purines and pyrimidines into RNA of 
pernicious anemia megaloblasts was normal, there was an impaired 
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incorporation of adenine, guanine, and cytosine into DNA. This was 
found to be ameliorated by addition of exogenous to the cultures. 
Role of Ribonucleotide Reductase 
In the light of the above evidence, attention was quite 
naturally directed towards the characteristics distinguishing the two 
polynucleotides from one another; i.e., the presence of deoxyribose 
and the replacement of uracil by thymine in DNA. An early hypothesis 
advanced by Beck^ in 1961, and restated more emphatically in 1965,^ 
focused on the B12~dependent ribonucleotide reductase present in 
Lactobacillus leichmanii. Beck developed an analogy between the 
morphologic and biochemical abnorma1ities produced in this organism by 
growth on a B^'depleted medium (long, filamentous organisms unable to 
divide, with impaired DNA synthesis in the face of normal RNA and 
protein synthesis) and the morphologic aberrations of mega 1ob1asts. 
He suggested that the pathogenetic lesion in pernicious anemia might 
be an inability to reduce ribonucleotides to their deoxy- analogues. 
One obvious conceptual flaw in this hypothesis was that it failed to 
account for the intimate nutritional relationships between folates and 
B-|2^ and for their interdependent roles in the development and 
amelioration of megaloblastosis.66,67 Furthermore, as experimental 
evidence accumulated, it became clear that the reductase of mammals 
differed markedly from that of j^. 1 e i chman i i in terms of substrate 
requirements and control mechanisms, resembling far more the B^" 
o r o 
independent reductase isolated from E_. col i .0 ’ Nevertheless, Beck 
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continued to advocate his position, citing unpublished studies from 
his own laboratories supposedly demonstrating the B^2~dependence of 
marrow reductase.^ In 1969, Fujioka and Silber reported their 
inability to stimulate marrow reductase with exogenous B^-^ 
Sufficient purification was not possible, however, to exclude the 
presence of enzyme-bound cobalamin in their preparations. An additional 
feature reminiscent of the E_. col i reductase, inhibition by hydroxyurea, 
was also found by Fujioka and Silber. Beck's studies apparently remain 
unpublished, and his hypothesis appears untenable at the present time. 
The properties of the different ribonucleotide reductases are summarized 
o 
in Table 2, modified from Silber and Moldow. 
The Hethylfolate Trap Hypothesis 
Following the elucidation of the role of vitamin B12 'n the 
methylation of homocysteine, Noronha and Silverman noted that methionine 
administered to B^2“dep1eted rats could eliminate their excessive FIGIu 
excretion, and also alter the distribution of folate coenzymes in liver 
from predominantly N^-CH-^-FH^ to N^- and N^-CHO-FH^. They concluded 
that the folates had been trapped, by B^ deficiency, as N^-CH^-FHZj, 
and that administered methionine had in some way acted as an acceptor 
for the folate methyl group, thus circumventing the trap and regenerating 
free FH^, which became an effective receptor for the formimino group of 
FIGIu.^ Herbert and Zalusky applied this concept to the clinical 
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anemia presented with serum folate levels elevated to a degree seen 
otherwise only in subjects ingesting large amounts of folic acid. 
They proposed that this may have represented a "piling up" of 
methylfolate in the serum,^ since most serum folate was N^-CH^-FH/^. 
To test this hypothesis, they infused 15 mcg/kg of folic acid intra¬ 
venously into normal control subjects and patients with folate, B12» 
of combined folate and Bj2 deficiencies. Folates other than N^-CH^-FH^ 
were cleared rapidly from the serum of all deficient subjects, but in 
the patients with untreated pernicious anemia N^-CH^-FH^ tended to be 
retained for several hours. This plateau was abolished after treatment 
with vitamin B^- Moreover, the initiation of B -j 2 treatment in 
pernicious anemia regularly induced a fall in plasma folate. On the 
basis of this evidence, they concluded that the underlying defect in 
mega 1ob1astosis was a generalized slowing of folate-mediated single¬ 
carbon transfers, and that B ^ 2 deficiency could bring this about in¬ 
directly through its role in the regeneration of FH^ from N5-CH^-FH^.^ 
They also suggested a re-interpretation of the findings of Noronha and 
Silverman more in keeping with the known roles of the individual 
metabolites; i.e., that methionine abolished FIGIu excretion by acting 
as an end-product inhibitor of the enzymes leading to the formation of 
N^-CH^-FH^. Herbert and Zalusky's "methylfolate trap hypothesis" has 
become the most widely accepted formulation attempting to account for 
the obviously intimate interrelationship of vitamin B^ and folic acid. 
Several studies tending to support this proposal shortly 
followed. In the most comprehensive of these, Waters and Moll in found 
the mean serum folate of 100 consecutive patients with untreated 
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pernicious anemia to be significantly higher than that of healty controls. 
Perhaps more revealing, the highest serum folates were found among 
patients with the lowest serum Bi2 levels, provided that the degree of 
anemia was minimal. The authors suggested that the lower serum folate 
seen inconsistently in more anemic subjects were a consequence of anorexia 
leading to true nutritional folate depletion in these patients. A fall in 
serum folate apparently precipitated by treatment was again observed.72 
That B^2 deficiency impairs utilization of plasma methyl- 
folate is by no means established with certainty. The results of some 
clearance studies have been distinctly at variance with Herbert and 
Zalusky's findings. Chanarin and Perry were unable to distinguish the 
clearance of infused synthetic N^-CH^-FH^ from the plasma of pernicious 
anemia patients as compared to control subjects; clearance was 
accelerated in folate-deficient patients.73 All such studies have 
been criticized as being highly nonphysiologic. Herbert's infusions 
produced peak serum folate levels of greater than 300 ng/ml in some 
subjects; in Chanarin's study the maximal concentrations were near 
50 ng/ml. The only parameter assessed in many patients was disappearance 
from plasma, which may be a very poor index of changes occurring in 
intracellular pools. Recently a clearance study in which some of these 
factors were better controlled has appeared.7^>75 ywo patients with 
pernicious anemia were given infusions of 5 mcg/kg of N^-^ ^CH-^-FH^-^H 
before treatment and again after establishment of remission with B12 
therapy. Three others were given only 0.05 mcg/kg of N^-CH-^-FH/j-^H . 
In the first group, serum folates were raised to greater than 50 ng/ml 
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five minutes after infusion. No rise in the serum folate was produced 
by the 100-fold smaller dose used in the second group. In the group 
given the much larger dose, there was insignificant delay of plasma 
clearance of N^-CH-^-FH^, as compared with post-treatment clearance rates. 
In the three patients to whom only tracer amounts were administered, 
clearance of methylfolate was definitely retarded, and was significantly 
accelerated by 1000 meg of CN-B]2 injected 24 hours after the infusion. 
No such enhancement of clearance by an injection of Bi2 was seen when 
the infusions were repeated with the patients in remission. Urinary 
excretion of the infused materials was found to be two- to four-fold 
greater before treatment. After therapy, greater utilization presumably 
accounted for less appearing in the urine. Moreover, while less than 
ten per cent of the lower dose of infused folate-^H appeared in the 
urine within 6 hours, forty-four per cent of the administered in 
the 100-fold larger dose was excreted in this same time period. In 
summary, the most "physiologic" studies reported to date strongly sug¬ 
gest that deficiency does result in reduced transfer of N^-CH^-FH^ 
from the plasma to body tissues. 
Based upon the assumption that increased endogenous methyl¬ 
folate pools would dilute production from exogenous N^-CH^-FH^, 
it has been suggested that such increased pools were not present in 
B^ deficient rats.76 Since the pathways by which the methyl group of 
methionine (and hence N^-CH^-FH^) is converted to CO2 are unknown, the 
actual meaning of this finding is unclear and may have little to do 
with methylfolate pool sizes. 

-33- 
The methyl folate trap hypothesis requires that, once formed, 
N^-CH^-FH/j can be metabolized only in the presence of the cobalamin- 
dependent methyl transferase. No role other than the methylation of 
homocysteine has been found for N^-CH^-FHAj in man. If, as suggested by 
Foster,a coba1 amin-independent transferase is also present, the trap 
would be ineffective, but there are no studies yet available which 
support Foster's contention. It would be anticipated that decreased 
activity of the methyl transferase would result in decreased de novo 
methionine synthesis. This is supported by the finding of low serum 
methionine levels in pernicious anemia which return to normal following 
B-\2 treatment.77 Accumulation of homocysteine would be expected also, 
and has been observed.78 
Methylfolate might also be released from the trap by re¬ 
oxidation to its precursor, N^N ^ ^-CH2-FH^. The enzyme involved, 
n5n10-methy1enetetrahydrofolate reductase, has been studied extensively 
from both mammalian liver and E_. col i . Although usually assayed in the 
"reverse" direction, by trapping of formaldehyde released nonenzymatica11y 
from N^N^-CH2_FH^79 as the dimedone adduct, 
FH k <- -> n5n10-ch2-fhZ| l5-CHo-FH, 
HCHO FADH' FAD 
NAD NADH, H+ 
the presence of an artificial electron acceptor, menadione, is necessary 
to drive the reaction in this direction. The enzyme from E_. col i , 
assayed in this manner, was found to have a Keq of 2400 favoring 
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reduction of methylenefolate. Assayed in the "forward" direction by 
monitoring FADH2 oxidation, the Keq was calculated at 3400. Only one 
of the methyl group hydrogens becomes labelled when N^N^FH^ is 
reduced enzymatically in tritiated water, also suggesting functional 
irreversibility.^ Although no thermodynamic data are available on 
the mammalian enzyme, they at least share similar pH optima. A some¬ 
what capricious attempt to circumvent the "trap" clinically was 
reported by Herbert et_ aj_. ,^1 who injected menadione, both intra¬ 
venously and directly into the marrow. No reticu1ocytosis, fall in 
serum folate, or reversion of the marrow morphology towards the normo¬ 
blastic state was observed. The authors admit that the study is 
uninterpretable. 
The regulatory role of methionine in the biosynthesis of 
methylfolate has also received considerable attention. Herbert and 
Sullivan demonstrated that in patients with megaloblastic anemia 
methionine suppressed FIGIu excretion. They suggested that inhibition 
of methylenefolate reductase could be responsib1e.^2 Dietary methionine 
supplementation did reduce the activity of the reductase from rat liver, 
but only by 25-50%.^ |n E_. col i , it was found that the presence of 
methionine in the growth medium resulted in low activities of the 
reductase in homogenates. The mechanism was not allosteric modification 
of the apoenzyme, since addition of methionine directly to homogenates 
did not reduce activity.^ In summary, these studies, if applicable to 
the human reductase system, would suggest that FHZ| cannot be re¬ 
generated by oxidation, and that methionine may exert its effect on 
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FIGIu excretion by repressing synthesis of the reductase. Such a 
sparing effect of methionine on folate trapping is at odds with Rundle 
and Brewer's single case report of a patient with pernicious anemia in 
whom methionine feeding seemed to accelerate the development of 
rel apse . ^ 
It has also been suggested that the effect of methionine in 
reducing FIGIu excretion is not a manifestation of liberation of 
"trapped" folates, but simply a result of competition for a common 
membrane transport mechanism for methionine and histidine, reducing 
delivery of the latter to catabolic pathways.^2 This seems unlikely 
in view of the observation that dietary methionine supplementation 
permitted normal ^CC>2 excretion from deficient rats given injec¬ 
tions of l^C-2 (i mi dazol e)-h i st i d i ne. 76 No such facilitation of 
histidine catabolism was observed in a single patient with untreated 
pernicious anemia,^ but ^CC>2 excretion was normal in this subject 
prior to methionine supplementation. 
The trap hypothesis obviously requires that N^-CH^-FH^ be 
totally ineffective in inducing remission in B^ deficiency. It has 
been impossible to obtain large enough quantities of methylfolate to 
test this directly. The ability of oral folic acid to elicit maximal 
hematologic responses raises questions about the metabolism involved in 
absorption of folates. Some studies have indicated that oral PGA is 
totally reduced and methylated by the intestinal mucosa,^ other 
studies that some oral PGA is absorbed unchanged>86 When both 
portal and systemic folates were analyzed after administration of 500 meg 
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of L-PGA, apparently the compound was absorbed unchanged, followed by 
extensive hepatic reduction and methylation (or displacement of liver 
methy1folate).^ While much remains unknown about the absorption of 
folic acid, present evidence suggests that at least some does enter 
the systemic circulation in reduced forms other than N^-CH^-FH^. 
This "untrapped" fraction might be sufficient to support hematopoeisis 
in pernicious anemia patients treated with oral PGA. 
Portal venous folates have also been characterized following 
ingestion of folinic acid (N^-CHO-FH/j) . This compound appeared to have 
been almost completely reduced to N^-Ch^-FHZf by the intestinal mucosa. ^ 
On the basis of this information, it was assumed that “for tissues 
other than the intestine, the feeding of folinic acid is equivalent to 
the feeding of 5~methy1tetrahydrofolate itself".^ Accordingly, a 
patient with untreated pernicious anemia was given 6 mg of folinic acid 
daily for 6 days. The brisk reticu1ocytosis and reversion of the 
marrow to normoblastic maturation which followed were considered to have 
disproved the trap hypothesis.^9 Several arguments can be raised 
against this conclusion. In the experiments upon which this study was 
based,^ approximately 15% (150 meg) of the active stereoisomer of each 
2 mg dose was absorbed into the systemic circulation unchanged. While 
the authors felt that the 450 meg/day of "untrapped" coenzymatic folate 
thus introduced would have been insufficient to produce the changes 
observed, this is inconsistent with abundant evidence that the daily 
folate requirement of man is only about 50 mcg.^O Moreover, it is well 
established that 400 meg/day of PGA is sufficient to produce a hema- 

-37- 
tologic response in folate deficiency.32 Finally, a recent study 
demonstrated that the 1 -C unit of orally administered N^-^CHO-FH^-^H 
is rapidly cleaved from its carrier, not simply reduced to methyl- 
folate. 91 This indicates that feeding of N^-CHO-FH^ is quite different 
from supplying pure methylfolate. 
An observation which may suggest a role for cobalamins in 
hematopoeisis, independent of effects on folate metabolism, is that B12 
seems to promote normal marrow maturation even in the "absence" of 
folate. Three folate deficient patients with megaloblastic anemias 
and normal serum levels who responded to B ^ 2 therapy with near- 
maximal hematologic responses have been reported.^7 Others have been 
unable to elicit such responses,92 and it can be postulated that the 
effect of B^ was to promote optimal redistribution of remaining 
folate coenzymes.^7 
Studies of Megaloblast Proliferation in vitro 
The methyl trap hypothesis as originally conceived proposed 
only a generalized impairment of nucleic acid biosynthesis brought 
about by interference with folate-dependent single-carbon transfer re¬ 
actions. For reasons discussed earlier, attention over the past decade 
has been focused on biochemical events peculiar to DNA synthesis. In 
1964, Schmid e_t_ a_l_. demonstrated that 54% of pol ych romatoph i 1 i c megalo- 
blasts, as opposed to only 23% of polychromatophi1ic normoblasts, were 
still actively synthesizing DNA. They suggested that megaloblastic 
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maturation was characterized by an increased percentage of "homoplastic" 
(non-differentiating) mitoses in the marrow.93 Elaborate studies of 
marrow cy tok i net i cs published in 19&7 and 1968 better character ized 
the aberrations of DNA biosynthesis in pernicious anemia mega 1ob1 asts. 
A greater percentage of megaloblastic than normoblastic cells were found 
to be in the G2 phase of the cell cycle, as demonstrated by their 
tetraploid (^tC) DNA content and failure to take up 3h -1 h y m i d i ne . While 
polychromatophi1ic normoblasts could easily be assigned to either the 
G1 ,S, or G2 phase of the cell cycle, megaloblastic marrows contained 
many polychromatophi1ic cells which were not engaged in DNA synthesis 
but yet had DNA contents scattered between the 2C and 4C amounts. 
These data were considered indicative of abortive DNA replication in 
mega 1ob1asts. The increased frequency of cells in the G2 phase was 
thought to suggest an inability of megaloblasts to enter mitosis fol¬ 
lowing completion of DNA replicat ion.9^>95 These observations were 
confirmed independently by Yoshida et_ aj_. ,^6 who found that the cell 
cycle abnormalities were eliminated within 2k hours of starting treat¬ 
ment with 1000 meg C N-B ^ 2• Yoshida's study also indicated that RNA and 
protein synthesis progressed at accelerated rates in megaloblasts from 
untreated patients. 
In 1968, a biochemical lesion in DNA synthesis consistent 
with the methyl trap hypothesis was demonstrated in cultures of marrow 
megaloblasts by Metz and coworkers.97 The methylation of deoxyuridine 
(dll) had earlier been shown to be impaired in Bi2_def i cient animals, 
and some workers had suggested that CH3-B12 functioned coenzymatica11y 
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in this reaction. Although others were unable to demonstrate such a 
r in 
requirement for the role of fPN -CH2-FHZ| as C-l donor was 
estab 1 i shed .98 Metz £t_ a_l_. incubated marrow cells in vitro with un¬ 
labelled dll and then added 3hl-thymidine (3H-dTR) to the cultures. 
In normal marrows, the dU preincubation was able to suppress incorpora¬ 
tion of subsequently added 3H-dTR into DNA to less than 10% of control 
(non-dU-preincubated) values. This effect was considered to indicate 
methylation of the dU and subsequent competition with the added ^q-dTR. 
In marrows from B1 2 -deficient patients, dU preincubation could not 
suppress 3n-dTR incorporation, indicating a "block" in methylation of 
dU. Addition of 1 meg of to the culture medium partially re¬ 
established the dU suppression, but 50 meg of PGA completely restored 
it. Even more striking was the finding that 50 meg of N^-cH3-FH4 was 
unable to restore dU suppression in B^2~deficient marrows, while it 
did so nearly as well as PGA in the marrow of a folate deficient 
patient. That the role of B^ was an indirect one was demonstrated 
by the ability of methotrexate to cancel its effect completely. These 
findings offered impressive support for the methylfolate trap 
hypothesis. It could now be postulated that the principal effect of 
the trapping of folates as N^-CH^-FH^ was the depletion of its im¬ 
mediate precursor, N^N^O-Cf^-FH^, the substrate for the methylation of 
dU.97 The inability of pernicious anemia megaloblasts to incorporate 




Metz's experiments were extended to study the effects of 
methionine and homocysteine on the defective dU suppression of 
megaloblastic marrows.99 As discussed earlier, methionine had been 
shown to reduce FIGlu excretion and somehow to release "trapped" 
folates in Bi2 deficiency. Surprisingly, methionine was found to block 
the corrective effect of B12 in pernicious anemia marrows. 99 End- 
product inhibition of homocysteine transmethylase, as suggested in 
rat liver,^ was invoked as a possible mechanism of this effect. 
Homocysteine partially restored dU suppression of ^H-dTR incorporation 
in pernicious anemia megaloblasts in the absence of or the presence 
of a B12 antagonist. Several interpretations of these findings were 
considered by the authors, including the presence of a B^2“>ndependent 
transmethy1ase which could regenerate FH^. Alternatively, homocysteine 
could have accepted some of the methyl groups of N^-CH^-FH^ nonenzymatic- 
ally by a mass action effect because of the large quantities of the 
amino acid present; 1 mg of homocysteine was added to the cultures, 
while only 50 meg quantities of folate coenzymes were sufficient to 
restore dU suppression. An alternative interpretation of the methionine 
effect, not suggested by the authors, would require that methionine 
suppressed not only N^N^0-CH2-FH^ reductase, but also pathways leading 
to the synthesis of methylenefolate. If this were the case, the avail¬ 
able pool of free FH^ for histidine catabolism would be increased by 
methionine, thus enhancing FIGlu breakdown; lack of l\|5|\|^(-)-CH2-FHi( would 
then lead to impaired dU methylation. No data in support of this 
hypothesis are available, and its plausibility is questionable in view 
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of the presence of a functioning non-enzymatic pathway in vivo for the 
production of N^N FH^ from FH^ and forma 1 dehyde . 79 
On the basis of the dU suppression studies, the cytogenetic 
abnorma1ities observed in megaloblasts have been interpreted as the 
result of thymidine deficiency, leading to single-strand breaks in the 
DMA helix. No differences in base composition of normal as opposed 
101 
to megaloblastic marrow cell DNA have been demonstrated, however. 
The Role of Cobalamins in Pernicious Anemia Neuropathy 
An attractive feature of the methylfolate trap hypothesis is 
that it seeks to explain the hematologic effects of B-]2 if terms of a 
folate-dependent action, and the neurologic effects of Bj2 if terms of 
a folate-independent function. It has been suggested that reduced 
activity of methy1ma1ony1 CoA mutase, the only other enzyme known in 
man to require a B^ cofactor, could in some way produce the sensory 
neuropathy of pernicious anemia. Recently some experimental support 
for this speculation has been developed. Sural nerve biopsy slices 
from pernicious anemia patients and control subjects, when incubated 
with i-propionate, both incorporated the label into fatty acids, but 
in the B^ deficient slices, label appeared extensively in anteiso-Ci5 
and C17 saturated acids, whereas in control subjects the labelling 
was of and acids. ^ |n rat glial cell cultures, cells grown 
in B^ deficient medium elaborated and acids, and propionate 
accumulated in the medium. These effects were reversible by Bi2 
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supplementation .103 The inference made from these findings is that 
the abnormalities of fatty acid biosynthesis observed in vitro may 
result in vivo in deranged metabolism of myelin surrounding peripheral 
nerves, and thus bring about subacute combined degeneration of the white 
matter of the spinal cord. A tremendous amount of speculation is 
required to postulate a causal relationship between the biochemical 
observations and the clinical lesions. At present, it seems prudent 
to regard the association as interesting but of undertermined 
significance. 
Implications of Inborn Errors of Folate and Metabolism 
That impaired nucleic acid biosynthesis is the primary lesion 
in megalob1astosis is supported by the appearance of megaloblastic 
anemia in orotic acidura, an inherited disorder characterized by one or 
more blocks in the pyrimidine biosynthetic pathway.The particular 
consequences of cobalamin-folate interdependence specified by the methyl 
trap hypothesis are supported by two recently described inborn errors 
of folate metabolism. Arakawa et_ aj_. studied an infant with megalo¬ 
blastic anemia, increased urinary FIGIu, and elevated serum L^. case i 
activity (N^-ChU-FH^) . They suggested that a deficiency of 
N^-CH^-FH^-homocysteine transmethy1ase was responsible for the clinical 
findings. Activity of the enzyme from liver was reduced to 30-50% of 
control values, but the range of activities of other enzymes measured 
was so great among "controls" that the reduction of transmethy1ase 
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activity in the patient could be considered to be within the limits 
of reproducibility of the assays. Also, no mention of homocystinuria, 
a possible consequence of such an enzymatic block, was made. 
Methylenetetrahydrofolate reductase deficiency has been 
reported in two sibships.^^ This block would not be expected to pro¬ 
duce megaloblastic anemia and apparently did not. Homocystinuria, 
presumably consequent to N5-cH-FH4 deficiency, was present in these 
patients. Surprisingly, neither serum nor tissue NS-CH^-FH^ levels 
were reported. Methyltransferase activities were normal. 
Inherited disorders of Bj2"dependent metabolism have also 
been described in recent years. ^7 Several children have now been 
reported with metabolic ketoacidosis and methylmalonic acidemia 
secondary to methylmalonyl-CoA mutase deficiency. The methyl trap 
hypothesis would predict no impairment of hematopoeisis resulting from 
such a block, and megaloblastic anemia has not been observed. The 
methylmalonic acidemia phenotype is now recognized to be genetically 
heterogenious, some patients apparently having a mutant apoenzyme, 
1 Q O 
others being unable to accumulate the coenzyme dA- B12 int race 1lularly.luo 
More profound genetic defects of cobalamin metabolism have also been 
described. An infant reported by Levy et al.^ ^ died at 7i weeks of 
age, ending a clinical course characterized biochemically by persistent 
hypomethioninemia, homocystinemia, and methylmalonic aciduria. 
Megaloblastic changes were not observed in marrow aspirates, but fre¬ 
quent transfusions were required to maintain the infant's hematocrit. 
Tissue enzyme analyses revealed depressions of the B-j 2_dependent methyl- 
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transferase and methylmalonyl“CoA mutase, which could be rerestored 
towards normal by high concentrations of the appropriate cofactors.^ 
The postulated enzymatic block in this child must be at a point common 
to the biosynthesis of both cobalamin coenzymes; i.e., transport into 
the cell or reduction of the central cobalt atom,^7 or some subsequent 
step required for formation of each coenzyme. A biochemically 
similar, though clinically less severe, lesion has been observed in 
two siblings by Goodman et a 1 . . ^ ^ , 11 3 Both of these children had 
methylmalonic aciduria and homocystinuria, but plasma methionine levels 
were normal. Neither had megaloblastic or macrocytic changes, and 
on this basis Goodman raised arguments against the plausibility of the 
methyl trap hypothesis. The diminution of methyltransferase activity 
was asserted to be at least as great in his patients as occurs in 
pernicious anemia, because of the magnitude of homocystine excretion 
in the two conditions. Methyl transferase activities have not actually 
been measured in human deficiency, but the reduced plasma methionine 
levels usually found would suggest a more profound reduction of methyl- 
transferase in untreated pernicious anemia. At present, the issue re¬ 
mains unsettled. The lack of mega 1ob1 astosis in the infant dying with 
a far greater reduction of methyl transferase activity is more difficult 
to explain, but in the presence of such a profoundly disturbed bio¬ 
chemical milieu, the marked erythroid hypoplasia observed might have 
obscured any tendency to megaloblastic changes. 
The possible role of the propionate — methylmalonate — 
succinate pathway in the pathogenesis of the neurologic manifestations 

of pernicious anemia has been mentioned earlier. Although clinical 
signs of dorsal column dysfunction have not been reported in either 
methy1ma1ony1-CoA mutase deficiency or the "combined defect" syndromes, 
mental retardation and hypotonia1^ have been prominent features. 
Autopsy has either not included the neuropathology^5 or demonstrated 
diffuse and focal softening of cerebral white matter.There is no 
justification at present for attributing the neurologic manifestations 
of these syndromes to the abnormalities of fatty acid biosynthesis 
observed in vitro in deficiency. 
Other Postulated Roles for 'n the Development of Mega 1 ob 1 as tos I s 
An unconfirmed report has appeared suggesting a role for 
CH3-B^2 'n methylation of tRNA.^7 it was suggested that in B^2 
deficiency, non-methylated tRNA would accumulate which would be less 
effective in amino acid transfer to ribosomes. The considerable 
evidence presented earlier suggesting normal protein synthesis in the 
face of impaired nucleic acid metabolism renders this hypothesis 
untenab1e. 
A "geographic" rather than metabolic folate trap has been 
postulated by Chanarin^^ to be the basis of megalobl astos i s in B12 
deficiency. Erythrocyte folates are reduced in approximately two-thirds 
of B^ deficient patients and return to normal following institution of 
therapy.This may simply be a reflection of an older peripheral 
red cell population rather than of impaired folate uptake by red cell 
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1 1 O 
precursors,110 The increased plasma/red cell folate "gradient" 
regularly observed in Q]2 deficiency^ and its rapid disappearance 
following initiation of therapy suggest that folate uptake is indeed 
impaired. Analysis of this proposition is complicated by the fact 
that intrace 11u1ar and extracellular folates are not freely exchangeable, 
the former being largely polyglutamates.^ Kutzbach et al. have 
speculated that the impaired folate polyglutamate accumulation of rat 
hepatocytes in B1 2 deficiency may actually represent another mani¬ 
festation of methyl trapping, if, as in E_. col ? , FHbut not N^-CH^-FH^ 
is the substrate for polyglutamate synthesis.^ (n the absence of any 
understanding of the functions of polyglutamates in mammalian systems,^0 
it is difficult to formulate any hypotheses explaining the known bio¬ 




PURPOSES OF THE PRESENT STUDIES 
Sufficiently sensitive assay techniques have not yet been 
developed to render practicable the measurement of intracel1u1ar 
folate coenzyme pools in the clinical setting. Knowledge of the 
metabolic roles of each of these compounds does make possible pre¬ 
diction of the consequences of depletion of individual coenzymes. 
Since the methyl trap hypothesis requires a relative deficiency of 
intracellular N^N^-CH2~FH^, estimations of the effective pool of this 
form of folate would be illuminating. As glycine-serine interconversion 
requires this coenzyme, it would be reasonable to expect this reaction 
to be impaired consequent to B ^ 2 deficiency, if the methyl trap 
hypothesis were correct. Because impaired formate incorporation into 
serine by peripheral lymphocytes has been reported to be a sensitive 
indicator of folate deficiency,^ the intact leukocyte would seem to be 
an ideal system in which to attempt confirmation of these expectations, 
it is also of importance to establish the specificity of the assay if 
it is to be used clinically as a diagnostic tool. 
Although not believed to be involved in the development of 
mega 1ob1 astosis , methylmalonyl-CoA mutase activity is known to be re¬ 
duced in deficiency'^ and may be a more specific indicator of the 
deficiency state because of its independence of folate metabolism. 
Recent publications suggest that this independence may not be total. 
Low serum B^ levels which rose following initiation of specific 
therapy have been found in 40-60% of patients with folate deficiency.121 
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Intraerythrocytic cobalamin levels have been reported to be universally 
low in folate deficiency. ^2 These observations suggest that an as yet 
unexplained B^-folate interaction may influence the cellular uptake 
of both vitamins and raise the possibility that deficiency of either 
will bring about deficiency of the other. The fact that methylmalonic 
aciduria has been reported not to occur in pure folate deficiency^3 
raises doubts about this hypothesis, but it is possible that a more 
sensitive assay would detect impaired B-j2~dependent metabolism. 
Impaired methylma1onate oxidation by peripheral leukocyte extracts has 
been reported to be a reliable test for Bj2 deficiency, even in the 
absence of significant methylmalonic aciduria,^ but the status of the 




MATERIALS AND METHODS 
At the time of study, all subjects but one were inpatients 
on the wards of the Yale-New Haven Hospital. Control subjects were 
healthy laboratory personnel. Prospective patients were selected by 
means of erythrocyte folate bioassay using Lactobacillus casei as the 
test organism;^ serum folate bioassay using the same organism; or 
plasma vitamin isotope dilution assay.^4 These tests are routinely 
performed by the hospital's clinical microscopy laboratory on all 
patients found by Coulter Counter Model S determination to have 
erythrocyte MCV's greater than or equal to 115 cubic microns.30 This 
screening program proved to be an effective tool for detecting un¬ 
suspected, and therefore untreated, folate and B}2 deficiences. A few 
patients thus identified were admitted to the Clinical Research Center 
for study and to investigate the etiology of their deficiencies. 
Patients receiving antimetabolite therapy were excluded from the study. 
Oral or written informed consent was obtained from all patients 
being studied. 
Preparation of Leukocyte Suspensions 
2 
Cells were prepared as described by Rosenberg et a 1.. 
Following an overnight fast, 15-30 ml of venous blood was drawn into a 
plastic syringe containing 90 units of sodium heparin (Sigma Chemical 
Co.). The blood was then mixed with an equal volume of \% (wt/vol) 
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polyvinyl pyrrollidone (PVP-36O, Sigma Chemical Co., average MW 360,000) 
in 0.9 g/100 ml NaCl containing 45 mg/100 ml D-glucose. The erythro¬ 
cytes were allowed to sediment for 45 minutes at 4°C at 140 x g for 
15 minutes. The supernatants were decanted and the pink cell pellets 
gently resuspended with pasteur pipettes in isotonic (0.8 g/100 ml) 
ammonium chloride containing 45 mg/100 ml D-glucose at 20°C. Ten 
minutes sufficed to lyse remaining erythrocytes; the cell suspensions 
were then centrifuged at 100 x g for 15 minutes at 4°C. The cell 
pellets were washed in ice-cold Kreb's bicarbonate buffer at pH 7-4 
(containing 45 mg/100 ml D-glucose), centrifuged again at 100 x g for 
15 minutes, and finally suspended in a volume of buffer sufficient for 
the assays. All procedures were carried out in plastic or nonwettable 
glass apparatus. Components of the buffer were as follows: 
Na+ 144.1 mEq/1 
K+ 6.0 mEq/1 
Ca++ 6.8 mEq/1 
Mg++ 2.4 mEq/1 
Cl" 130.6 mEq/1 
H2P04- 1.2 mEq/1 
SO^- 2.4 mEq/1 
HCO3" 25.1 mEq/1 
0.1 ml aliquots of cell suspensions were diluted in 1.9 ml 
of 4% acetic acid for enumeration by hemocytometer under phase 
microscopy. Final concentrations of leukocytes were between 6 x 10^/ml 
and 30 x 10^/ml. 
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Oxidation of 1 Ac~3~P rop i onate and ^C-1 A-Succ i nate 
Incubations were carried out in an apparatus developed by 
O 
Hsia, shown in Figure A. Teflon tubes which fit snuggly into the 
mouths of scintillation vials were modified for the assay by drilling 
four holes of approximately 2 mm diameter about the perimeter of the 
tube (A, Figure A). The tubes were then inserted into scintillation 
vials containing 0.5 ml "Hyamine" alkali so that the holes were 
occluded by the vial necks. 1.65 mcmole (0.25-1.69 mcCi) 
Na ^C-3-prop i onate or 1 .65 mcmole (0-34-1 .50 mcCi) ^C-1 , A-succ i n i c 
acid (both purchased from New England Nuclear Co.) in a total volume 
of 0.1 ml was placed in each tube. 0.9 ml of leukocyte suspension 
was added to each. The tubes were gassed for 1 minute with a 95% O2: 
5% CO2 mixture, sealed with rubber stoppers (Figure AB) , and incubated 
for three hours at 37°C in a Dubnoff metabolic shaker. 
At the conclusion of the incubation period, ^C02 formed from 
l^C-labelled substrates was collected by placing the vials in ice with 
the tubes pushed about 0.5 cm farther into the vials, thus establishing 
continuity between the gas phases of the sealed tubes and the vials, 
and the reactions were terminated by injection of 1.0 ml of 6 N b^SO^ 
into the incubation mix (Figure AC) . The evolved CO2 was collected in 
the Hyamine over 30 minutes, with a yield of at least 85%.^5 The 
apparatuses were disassembled, 10 ml of toluene - Liquifluor (New 
England Nuclear) added to each vial (Figure Ad) , and the radioactive 
^C02 counted in a Packard liquid scintillation spectrometer. Counts 
were corrected for quenching by the channels ratios method. Normal con- 
! '! 
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Figure 4. Apparatus used for leukocyte oxidation of propionate 




trol cells and cell-free blanks were run simultaneously with each 
assay. Results were calculated as nmoles of CO2 evolved from the 
substrate over the 3 hour incubation per 10$ leukocytes. 
Formation of ^C-L-Serine from L-Glycine and Na ^C-Formate 
Assay conditions were modified from those described by 
Ellegaard and Esmann.^ 0.9 ml of leukocyte suspensions were pipetted 
into nonwettable glass scintillation vials containing 0.1 ml of 
"formate substrate" such that final incubation concentrations were 
calculated to be glucose 6.6 mM, L-glycine 20 mM, and Na I^C-formate 
(New England Nuclear Co., s.a. 58.6 mC/mmole) 41 nmoles/ml. The vials 
were gassed for one minute with 95% O2: 5% CO2, capped, and agitated 
gently for four hours at 37°C in a Dubnoff shaker. Incubations were 
terminated by heating the vials for two minutes in a 95°C water bath. 
Normal control cells and cell-free blanks were run simultaneously with 
each assay. 
After heating, the suspensions were transferred to glass 
centrifuge tubes, centrifuged at 250 x g for 10 minutes, and portions 
of the supernatants removed for separation of ^C-L-serine. 
Separation of ^C-L-Ser?ne from Na ^C-Formate 
Serine was separated by a modification of the isoionic exchange 
chromatographic technique described by Thauer et al..^ Columns (l cm 

inside diameter) were filled with 1.5 g of moist resin (Dowex 2-X8, 
200-400 mesh), converted to formate from with 2 N ammonium formate.9 
Initially, several eluent solutions were used. It was found that when 
2.0 ml samples, acidified to a final concentration of 0.01 N trichlor¬ 
oacetic acid (TCA) were applied to the columns and washed in with 1.0 
ml H2O and 1.0 ml of acid eluent, approximately 96% of applied 
^C-L-serine appeared in the initial 4.0 ml of eluate (Figure 5). 
Elutions were continued with increasing concentrations of formic acid 
or with 0.4 N sulphuric acid; with each of these it was consistently 
found that ^C-formate was retarded beyond the volume containing serine 
(Figure 5). For routine assay, therefore, acidified 2.0 ml samples 
were applied, washed in with 1.0 ml of H2O and 1.0 ml of 0.05 N HC00H, 
and the corresponding 4.0 ml collected and its radioactivity counted 
(1.0 ml aliquots in 9-0 ml of "Aquasol", New England Nuclear Co.). 
Quench correction was by the channels ratios method. Radioactivity in 
the initial 4.0 ml eluate was assumed to be ^C-3-L-serine derived from 
1^C-formate, and results were calculated as nmoles ^C-L-serine formed 
per 1O^ leukocytes over the four hour incubation period. 
aThauer125 prepared columns with 4 N ammonium formate. The concentration 
change was required to enable solubility of the initial column eluate 










Figure 5. Isoionic Exchange Chromatography of -^C-L-Serine and 
Formate. 
A: l^p-L-Serine, eluted with formic acid (0.05p Ci, 0.2 N HCOOH. 
95.6 % of applied ^C-L-serine appeared in the 
first 4.0 ml of eluate). 
B: 14c-Formate, eluted with sulfuric acid. (0.6 pCi, eluted with 
1.0 ml of 0.05 N HCOOII and 15.0 ml 0.4 N H?S04. 
96.7 % of applied 14c_formate eluted as a discrete 
peak). 
C: l^c-poj^ate, eluted with formic acid (0.6 pCi, 0.2 N HCOOH. 93 % 
of applied l^c-formate eluted as a discrete peak). 
D: eluted with dilute formic acid (0.6 pCi, 0.05 N 
HCOOH. 12.9 % of applied l^C-formate had appeared 





Studies of the Leukocyte Serine Hydroxymethylase Assay 
in order to ascertain the effects of changes in assay 
I^C-formate concentration on net incorporation into ^C-serine, 
replicate assays were run with varying amounts of ^C-formate in the 
incubation mixes, yielding the following results: 
nmoles Ser 
Cel 1 Count 











Since a more than threefold increase in incubation l^C-formate concen¬ 
tration produced no more than a 50% increase in formation of radio¬ 
active serine, it was concluded that at the concentrations tested, 
formate concentration was not the rate-1imiting factor in total 
incorporation.a 
Activity of serine hydroxymethylase was also sought in diploid 
human fibroblasts. These cells proved to incorporate ^C-formate into 
serine at a rate approximately fifty times that observed in peripheral 
1eukocytes. 
aThis contrasts with the findings of Ellegaard and Esmann^3 who observed 
a linear relationship between ^C-formate concentration and ^C~3~ 
serine formation in lymphocyte suspensions. 
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In one preliminary experiment, replicate leukocyte suspen¬ 
sions were incubated with and without added glycine in the substrate 
solution. In the absence of exogenous glycine, ^C-serine formation 
was reduced by approximately 50%.a 
To confirm the identity of the eluate fraction collected and 
counted as ^C-serine, 3-0 ml of the initial 4.0 ml eluate from one 
set of assays were taken to dryness in a vaccum dessicator, 0.02 ml 
(0.2 mcC) of 3H-L-Serine (New England Nuclear Co.) and 0.18 ml of 
distilled water were added to each, and 0.1 ml of the resulting 
solutions were spotted on Whatman 3MM chromatography paper. This was 
subjected to electrophoresis at 2500 volts for six hours, using 6% 
formic acid as the mobile phase in a petroleum distillate (Varsol) 
bath. The e1ectrophoretograms were cut into 1 x H inch strips and 
counted in "Liquif1uor"-toluene in a Packard Tri-Carb liquid 
scintillation spectrometer with window widths and gains adjusted for 
maximum counting efficiency with minimal contamination of the low 
energy (3h) channel by disintegrations. It was found that no 
peak appeared in the electrophoretograms of cell-free blanks, and that 
a single peak, migrating precisely with marker 3H-L-serine over 
23 inches, appeared in the eluates from live cell incubations. As no 
other peaks were detected, this confirmatory procedure was omitted 
from routine assays. 





A1: A 59 year old Caucasian male cook seen in the emergency room 
because of pleuritic chest pain and found incidentally to have a 
high MCV. Diagnosis based on demonstration of histamine-fast 
achlorhydria and Schilling tests (Stage 1: 1.0% excretion; 
Stage II: 10% excretion). 
A2 : An 8k year old Swedish-American widow with an anemia unresponsive 
to iron therapy. Diagnosis made on the basis of histamine-fast 
achlorhydria and Schilling tests (0.8% excretion without intrinsic 
factor; k.2% excretion with intrinsic factor). 
A3: A 60 year old Caucasian housewife, presumed to have pernicious 
anemia on the basis of a Stage I Schilling test yielding only 
1.3% excretion of the ingested isotope over 2k hours. 
Other deficient patients-- 
B1: A kk year old woman with heterozygous /3-thalassemia admitted to 
the hospital for drainage of a chronic subdural hematoma following 
resection of an intracerebral meningioma. She had been taking 
oral diphenylhydantoin for 9 months at the time of study and had 
been transfused with 2 units of packed red cells one week prior 
to study. Stage I Schilling test revealed normal absorption of 
Bi2» Her B^ deficiency was presumably a secondary phenomenon 
produced by profound folate deficiency. 
B2: A k8 year old massively obese Caucasian woman with an undiagnosed 
neurological disorder characterized by reduced motor function 
below Cc; with intact sensory modalities in all four extremities. 
At the time of study she was on a zero Calorie diet with daily 
oral 5 mg PGA supplements. Bone marrow aspiration, gastric 
secretion studies, and Schilling tests were not performed on this 
patient. The etiology of her Bi2 deficiency is not established. 
Folate deficiency-- 
C1: A 25 year old Caucasian woman with intractible temporal lobe 
epilepsy, taking oral diphenylhydantoin. 
C2: A k2 year old housewife admitted for hysterectomy because of a 




Clinical laboratory data on all patients studied are summarized in 
Table 3- 
Oxidation of ^C~3~P rop i onate and ^C~ 1 ,4-Succ i nate 
As shown in Table 4, patients with vitamin B|2 deficiency, 
whether or not resultant from pernicious anemia, uniformly demonstrated 
a substantia 1 1 y reduced capacity to oxidize ^C-Propionate to 
lZfC02, consistent with impairment of the methylmalonyl-CoA mutase re¬ 
action. Oxidation of succinate by pernicious anemia patients was 
slightly increased as compared to controls, but no significant dif¬ 
ference in succinate oxidation was observed between control subjects 
and B^2“deficient patients without pernicious anemia, or between con¬ 
trols and all B]2"deficient subjects as a group. 
Two folate deficient patients studied showed no measurable 
defects in oxidation of either propionate or succinate. Patient B1, 
listed as Bi2 deficient, was in addition profoundly folate deficient 
as wel1. Her serum B1 2 level rose spontaneously to 200 pg/ml within 
48 hours of initiation of folate therapy. 
Figure 6 contrasts the mean propionate oxidations of individual 
B^ deficient subjects with the values observed among normal controls. 
Comparison with laboratory data from Table 3 illustrates that the degree 
of impairment of the methylmalonyl-CoA mutase activity of leukocytes 
does not seem to correlate with either the degree of anemia or the 
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I ncorporat i on of ^C-Formate into ^C-L-Serine 
deficient patients, taken as a group, demonstrated a 
highly statistically significant reduction in the capacity of their 
leukocytes to incorporate I^C-formate into labelled serine (Table 5)• 
This was not simply a result of concomitant "quantitative" folate 
deficiency, since patient A3 had the greatest individual reduction in 
serine formation but the highest levels of red cell and plasma folates. 
Of interest is the fact that, judged by severity of anemia, her Bi2 
deficiency was also the most profound among the pernicious anemia 
patients. 
The mean pre-treatment values for ^C-formate incorporation 
into serine by individual patients are illustrated in Figure 7- 
An unanticipated finding was a rather striking correlation 
observed between the reduction of propionate oxidation and impairment 
of serine formation by leukocytes of the B■)2 deficient patients. 
This is illustrated in Figure 8. 
Only two patients with folate deficiency unaccompanied by 
B12 deficiency were found for study. As seen in Table 5, no impairment 
of Glycine - Serine interconversion was detected. Both of these 
patients were studied several days after admission to the hospital, and 
the ingestion of a folate-rich diet may have restored this function to 
normal before the assays were performed. Neither of these patients had 
marrow aspirations or reticulocyte counts done prior to the day of 
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0 C2 (2) 
Cl (2) 
+ B2 (2) 
A2 (4) 
* B1 (4) 
X A1 (4) 
+ A3 (2) 
Figure 7. Incorporation of ^C-formate into ^C-L-serine by intact 
leukocytes from controls and patients. Control data are presented 
as mean _+ one standard deviation. Values for patients represent 
the mean of the number of observations in parentheses. Subjects 
are identified as follows: 
+: Patients with pernicious anemia 
*: Other B-j? deficient patients 
°: Folate deficient patients 
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nmoles ^C-Ser/ 10^ WBC/ 4 hours 
Figure 8. Correlation Between Serine Formation and 
Propionate Oxidation among Bp Deficient Patients. 
+: Pernicious anemia patients 
*: Other Bp deficient patients 
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Table 3 was also studied. This was a 26 year old woman with non- 
tropical sprue who had had a plasma folate level of 1.2 ng/ml one week 
prior to study. Serine hydroxymethy1ase activity of her leukocytes 
was assessed on the third day of PGA therapy, at which time her serum 
folate level was 24.6 ng/ml and her RBC folate 130 ng/ml. Reticulo¬ 
cyte count on the day of assay (5-4%) indicated active response to 
treatment, and incorporation of formate into serine was 9-8 nmoles/10^ 




Oxidation of Propionate in Deficiency 
In ruminants, the propionate - methylmalonate - succinate path¬ 
way (Figure 9) plays a significant role in energy metabolism, but in 
other mammals it appears to function principally in the oxidative 
catabolism, via the tricarboxylic acid cycle, of several of the 
essential amino acids, odd-chain fatty acids, cholesterol, and thymine. 
Depletion of vitamin B^, one of the cofactors in this series of re¬ 
actions, has been shown to result in increased urinary excretion of 
methylmalonic acid.^ Recently, Contreras and Giorgio have presented 
more direct in vitro evidence of a reduction in activity of the 
coba1 amin-dependent methylmalonyl CoA mutase consequent to vitamin B]2 
deficiency. In their studies, leukocyte homogenates from patients with 
pernicious anemia demonstrated a decreased capacity to oxidize racemic 
1 4c (carboxy) methylmalonyl CoA to This defect could be 
partially overcome by addition of large amounts of the "missing" co¬ 
factor, dA-B^j to the homogenates. The present studies confirm some 
of these findings. Intact leukocytes from patients with vitamin Bi2 
deficiency uniformly demonstrated a decreased capacity to oxidize 
14c- 3-propionate to ^CC^. That this diminished ^CC>2 production was 
caused by depressed activity of methylmalonyl CoA mutase is strongly 
suggested by demonstration that oxidation of ^C-1,4-succinate was 
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relation was observed between severity of Bi2 deficiency, as assessed 
by the usual indices of depletion (mac rocytos i s, serum level, 
degree of anemia), and the magnitude of the reduction of propionate 
oxidation. Similar absence of such correlations were found by 
Contreras and Giorgio, who also failed to demonstrate any relationship 
between the magnitude of urinary methylama1onate excretion and the 
severity of impairment of mutase activity. 
The extremely high values for ^C-1 , A-succ i nate oxidation 
seen in one B-\2 deficient patient in the present study may have 
represented a chance phenomenon, but they could also be indicative of 
the severity of the block in methy1ma1onate isomerization. If the 
endogenous production of succinyl CoA were diminished by reduced 
methylmalonyl CoA mutase activity, exogenous ^C-succinate would con¬ 
stitute a greater fraction of the total pool, resulting in increased 
^CC^ production from this tracer. As seen in Figure 6, this hypothesis 
tends to be supported by the data from the patients studied; leukocytes 
demonstrating the least severe impairment of propionate oxidation also 
had the lowest values for ^CC>2 production from added *^C-1 ,4-succ i nate. 
The number of patients studied is not large enough, however, to 
attribute definite significance to this observation. 
Contreras and Giorgio also studied the oxidation of methyl- 
malonyl CoA by homogenates of leukocytes from six patients with anemias 
not attributable to vitamin B ^ 2 deficiency (five with low serum folates, 
and one with iron deficiency resulting from blood loss). Four of the 
six demonstrated as severe a reduction in methylmalonyl CoA oxidation 
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as was observed in leukocytes from pernicious anemia patients. The 
data from this group of patients are extremely difficult to interpret, 
because of the absence of suitable controls demonstrating integrity 
of the remainder of the pathway leading to ^C02, and all of these 
patients appeared to be severely ill. Although five of the six were 
"folate deficient" none could be considered representative of pure 
nutritional folate deficiency. Nevertheless, the finding of reduced 
mutase activity is of interest in the light of the suggestion that 
folate deficiency does lead to reduction of intracellular cobalamin 
levels.^2 Measurement of urinary methylmalonate excretion would have 
been of interest in these patients, but this was not done. In the 
present studies, no impairment of propionate oxidation by intact 
leukocytes from two folate deficient patients was observed. Because 
neither of these patients was anemic, direct comparisons with Contreras 
and Giorgio's folate deficient subjects, all of whom had hemoglobin 
levels less than 10 g/100 ml, are perhaps unjustifiable. Succinate 
oxidation seemed also to be unimpaired in the two folate deficient 
patients studied here, which is at variance with the suggestion of 
Degrazia et_ aj_. that folate deficiency may for unknown reasons reduce 
capacity for succinate oxidation in v i vo. ^7 
Contreras and Giorgio demonstrated that, under the conditions 
of their assay, Bi2 deficient leukocyte homogenates were unable to 
utilize CN-B12- That intact leukocytes can do so has recently been 
demonstrated in vitro in cells derived from B^ deficient pigs.^8 
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Several lines of evidence discussed earlier suggest that 
integrity of the propionate pathway is not essential to normal hema- 
topoeisis. When pernicious anemia patients have been treated with B]2> 
methylmalonate excretion^23 and impaired in vivo oxidation of 
^C-2-propionate^9 have persisted for some time following establish¬ 
ment of hematologic remission. In the inborn error of metabolism, 
methy1malonicacidemia, in which only this pathway is impaired, 
administration of methionine aggravates methylmalonate excretion,^30 
but such an effect is not observed in pernicious anemia.^31 Exogenous 
deficiency is thought to interfere with both pathways requiring 
the vitamin. Since methionine is catabolized first by demethy1 ation 
to homocysteine and then through the propionate pathway (Figure 8), no 
increase in methylmalonate excretion would be expected to be provoked 
by methionine administration to B-|2 deficient patients. 
Formation of Serine in B]2 Deficiency 
The present studies demonstrate a decreased capacity of 
peripheral leukocytes from patients with deficiency and megalo- 
blastosis to incorporate ^C-formate into serine. This strongly sup¬ 
ports the "methy1folate trap" hypothesis, since the most plausible 
explanation of the finding is that B^ deficiency produced depletion of 
free FH^ available to combine with the exogenous ^C-formate. These 
findings are in agreement with the observations of Metz et_ a_K , who 
suggested that N^N ^-Ch^-FH^ pools were reduced in B12 deficiency 
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because of impaired deoxyuridine methylation by megaloblasts from 
patients with pernicious anemia.97 The results of the present experi¬ 
ments also indicate that defective ^C-formate incorporation into 
serine cannot be considered a sensitive and specific index of folate 
deficiency, as has been suggested by Ellegaard and Esmann.^ Contrary 
to the claims of these authors, assessment of this function was not 
found to be of value in the detection of minimal folate deficiency. 
Several possible explanations for this discrepancy can be postulated. 
Ellegaard and Esmann assayed formate incorporation by lymphocytes, 
whereas the present studies were conducted on mixed leukocyte populations 
containing approximately 75% granulocytes. The latter are short-lived 
in the peripheral circulation. Since the two folate deficient patients 
studied here had been on hospital diets for at least 3 days prior to 
collection of blood for the assay, it is conceivable that a new, 
folate-repleted population of granulocytes may have appeared during 
that interval. Since little is known about the kinetics of folate up¬ 
take and storage by polymorphonuclear 1eukocytes,132 it may be un¬ 
justifiable to attribute the differences observed to the cell types 
studied. 
Objections can be raised against the choice of formate as 
the radioactive substrate in both of these studies. Formation of 
NlO-CHO-FH^ requires ATP as well as FH^ and formate. The equilibrium 
for dehydration of N^CHO-FH^ to n5n 10-CH= FH^ lies far in the direction 
of NlO-CHO-FH/j at physiologic pH. NADPH is required to reduce the 
n5n10-ch=fh2+ to methy1enefolate.^33 Formaldehyde, on the other hand, 

reacts rapidly and non-enzymatica11y with FH^ to generate methyl- 
enefolate. Formate was chosen as substrate solely because of the ease 
with which it could be separated from serine. 
Implications and Unresolved Issues 
Taken in concert, the studies of propionate oxidation and 
glycine-serine interconversion here reported are consistent with the 
currently accepted hypothesis of the metabolic effects of B]2 
deficiency. Folate-dependent metabolism was impaired in 812 deficiency, 
but dependent metabolism was unaffected by folate deficiency. 
Recently, a new inborn error of metabolism has been recognized which 
raises doubts about the hematologic significance of this now well- 
established interaction of the two vitamins. Hakami et_ aj_. described 
two infants with megaloblastic anemia in the neonatal period which was 
shown to be caused by congenital deficiency of transcoba1 amin II, the 
^-globulin which seems to be important in facilitating cellular B^ 
uptake.Both of these siblings responded to massive frequent Bj2 
injections, but when B^ therapy was withdrawn in one, prompt relapse 
into a profound megaloblastic anemia ensued within six weeks. No 
abnormalities of either known B]2"dependent reaction could be detected 
well after mega 1ob1astosis had developed.^35 It was suggested by the 
authors that an as yet unappreciated role of Bi2 must be involved in 
the production of megalob1astosis. It is difficult at present to assess 
the significance of these findings. The assertion that both the mutase 
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and transmethy1ase enzymes were continuing to function normally in the 
face of unequivocal megaloblastosis was based on very gross indices 
(lack of methylma1onate excretion, homocystine excretion, or fall in 
plasma methionine). Nevertheless, the fact that pernicious anemia 
patients treated with folate eventually relapse hematologica11y even 
while on folic acid3! suggests that more remains to be learned about 
cobalamin-folate interactions. In the light of the plasma/red cell 
folate gradient observed in deficiency, the similar B]2 gradient 
seen in folate deficiency, and the sequence of metabolic events 
occurring in development of anemia in transcoba1 amin II deficiency, a 
search for interactions of cobalamins and folates at the cell membrane 
might be productive. A possible mechanism for B^2“dependent cell 
folate uptake has just been suggested by Tisman and Herbert.^35 These 
investigators found that marrow cell uptake of 3h-] abel 1 ed N^CH^-FH^ 
was impaired in megaloblasts from pernicious anemia patients, and that 
uptake could be increased 10-30% by addition of CN-B-j2 to the cultures. 
Cell uptake of PGA was not significantly reduced in the pernicious 
anemia patients and was not stimulated by CN-B^- The authors 
speculated that a membrane-bound, B^2“dependent transmethylase might 
play a role in uptake of serum methylfolate and that reduced activity 
of this enzyme in B^ deficiency could account for the serum/cell folate 
gradients seen in pernicious anemia. 
The striking correlation observed in the present studies 
between the degree of impairment of folate-dependent serine formation 
and B-j2“dependent propionate oxidation among B12 deficient patients 
* 
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(Figure 8) is consistent with a role for <n cell folate uptake. 
Serine hydroxymethy1ase and methy1ma1ony1 CoA mutase share no known 
cofactor requirements. The data therefore suggest that availability of 
coenzymes for both; i.e., N^N^O-CP^-FH^ and dA-B^, way be limited 
proportionately by a given degree of B^ deficiency. This correlation 
is not necessarily inconsistent with the methylfolate trap hypothesis. 
If the rate-1 i mi t i ng step in B^ coenzyme formation were an early one 
common to both CH3-B12 and dA-B]2> the observed relationship might be 
expected. According to the hypothesis, serine formation is indirectly 
B ] 2"dependent, since the regeneration of FHzj requires the presence of 
sufficient CH3-B12 to catalyze the homocysteine transmethy1ase re¬ 
action. Proportionate depletion of both B12 coenzymes could in this 
manner result in similar reductions in the pool of free intracel1ular 
FH and hence N^N^(->-CH2 - FH ,4. Total production and ^C-serine 
formation are influenced by many factors in addition to coenzyme 
availability, such as the rates of apoenzyme synthesis and the affinities 
of the apoenzymes for their substrates and cofactors. The observed 
proportionate impairment of these two metabolic functions in a small 
number of B12 deficient patients thus raises the need for further 
studies to establish its metabolic basis. 
One of the goals of the present undertaking was to achieve 
simplification of Ellegaard and Esmann's rather tedious assay. Although 
details were omitted from their brief report, they employed ion exchange 
chromatography followed by metaperiodate oxidation of the isolated 
serine, yielding ^CF^O specifically from the |3~carbon of serine. ^37 
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The modifications introduced in the present studies, although simpler, 
may have diminished the specificity or sensitivity of the test. The 
results obtained here from study of only two folate deficient patients 
must be regarded as extremely preliminary, requiring confirmation in a 
larger series of patients. An alternative simplified metaperiodate 
assay specific for the /3 -carbon of serine^S might be an appropriate 
tool to use in such future studies of glycine-serine interconversion in 
folate deficient patients. One of the goals of such studies would be 
to ascertain what, if any, correlation exists between integrity of the 
glycine-serine pathway and other measures of body folate stores, such 
as the red cell folate. It remains to be demonstrated whether or not 
the assay here developed can be adapted as a clinically useful test of 
folate deficiency. Studies of glycine-serine interconversion in intact 
leukocytes from folate deficient patients incubated in vitro with various 
folate compounds might reveal information about the largely unexplored 
area of folate transport in leukocytes. Future experiments might also 
be directed towards assessment of the effects on glycine-serine inter- 
conversion of anticonvu1sants and antifolate antimetabolites. 
The demonstration of high levels of serine hydroxymethy1ase 
activity in cultured fibroblasts suggests an alternative approach to 
the study of cellular metabolism in Bj2 and folate deficiencies. These 
cells are known to contain homocysteine transmethylase1^ and methyl- 
malonyl CoA mutase,^^ and their uptake of vitamin B12 is stimulated 
by Transcoba 1 ami n II. ^39 Fibroblasts cultured with dialyzed sera in 
selectively deficient media might yield a readily available, reproducible, 
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intact-cell system in which coba1 amin-folate interrelationships could 
be further elucidated. 
Although the present work strongly suggests that alterations 
in intracellular folate pools occur consequent to vitamin B-j2 deficiency, 
the roles played by such disturbances in the genesis of megaloblastosis 
will not be conclusively elucidated until the pools themselves can be 
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